Format

Send to

Choose Destination
Mol Med. 2009 Mar-Apr;15(3-4):101-14. doi: 10.2119/molmed.2008.00116. Epub 2008 Dec 3.

Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance.

Author information

1
Department of Experimental Physiology, Medical School, National and Kapodistrian University of Athens, Goudi-Athens, Greece.

Abstract

Disseminated malignancy is the major cause of prostate cancer-related mortality. Circulating tumor cells (CTCs) are essential for the establishment of metastasis. Various contemporary and molecular methods using prostate-specific biomarkers have been applied to detect extraprostatic disease that is undetectable by conventional imaging techniques, assessing the risk for disease recurrence after therapy of curative intent. However, the clinical relevance of CTC detection is still controversial. We review current literature regarding molecular methods used for the detection of CTCs in the peripheral blood and bone marrow biopsies of patients with prostate cancer, and we discuss the methodological pitfalls that influence the clinical significance of molecular staging.

PMID:
19081770
PMCID:
PMC2600498
DOI:
10.2119/molmed.2008.00116
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Feinstein Institute Icon for PubMed Central
Loading ...
Support Center